Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen
Seiji Kawamoto, … , Craig Gerard, Raif S. Geha
Seiji Kawamoto, … , Craig Gerard, Raif S. Geha
Published August 1, 2004
Citation Information: J Clin Invest. 2004;114(3):399-407. https://doi.org/10.1172/JCI19082.
View: Text | PDF
Article Immunology Article has an altmetric score of 3

The anaphylatoxin C3a downregulates the Th2 response to epicutaneously introduced antigen

  • Text
  • PDF
Abstract

Mechanical injury to the skin results in activation of the complement component C3 and release of the anaphylatoxin C3a. C3a binds to a seven-transmembrane G protein–coupled receptor, C3aR. We used C3aR–/– mice to examine the role of C3a in a mouse model of allergic inflammation induced by epicutaneous sensitization with OVA. C3aR–/– mice exhibited an exaggerated Th2 response to epicutaneous but not to intraperitoneal sensitization with OVA, as evidenced by significantly elevated levels of serum OVA-specific IgG1 and significantly increased secretion of the Th2 cytokines IL-4, IL-5, and IL-10 by antigen-stimulated splenocytes. Presentation of OVA peptide by C3aR–/– APCs caused significantly more IL-4 and IL-5 secretion by T cells from OVA–T cell receptor (OVA-TCR) transgenic mice compared with presentation by WT APCs. C3a inhibited the ability of splenocytes, but not of highly purified T cells, to secrete Th2 cytokines in response to TCR ligation. This inhibition was mediated by IL-12 secreted by APCs in response to C3a. These results suggest that C3a-C3aR interactions inhibit the ability of APCs to drive Th2 cell differentiation in response to epicutaneously introduced antigen and may have important implications for allergic skin diseases.

Authors

Seiji Kawamoto, Ali Yalcindag, Dhafer Laouini, Scott Brodeur, Paul Bryce, Bao Lu, Alison A. Humbles, Hans Oettgen, Craig Gerard, Raif S. Geha

×

Total citations by year

Year: 2024 2022 2021 2018 2017 2015 2014 2013 2011 2010 2009 2008 2007 2005 Total
Citations: 1 1 1 2 2 3 2 3 1 1 5 1 2 4 29
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (29)

Title and authors Publication Year
Indoor microbial exposure increases complement component C3a and C-reactive protein concentrations in serum
Karhuvaara O, Vilén L, Nuutila J, Putus T, Atosuo J
Heliyon 2024
The role of complement in nonalcoholic fatty liver disease
Guo Z, Fan X, Yao J, Tomlinson S, Yuan G, He S
Frontiers in immunology 2022
Complement Component C3: A Novel Biomarker Participating in the Pathogenesis of Non-alcoholic Fatty Liver Disease
J Han, X Zhang
Frontiers in Medicine 2021
The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis
J Dick, PY Gan, AR Kitching, SR Holdsworth, JC Crispin
PloS one 2018
The Anaphylatoxin C3a Receptor Expression on Human M2 Macrophages Is Down-Regulated by Stimulating the Histamine H4 Receptor and the IL-4 Receptor
Mommert S, Aslan D, Ratz L, Stark H, Gutzmer R, Werfel T
Journal of Innate Immunity 2018
Immune recognition of salivary proteins from the cattle tick Rhipicephalus microplus differs according to the genotype of the bovine host
GR Garcia, SR Maruyama, KT Nelson, JM Ribeiro, LG Gardinassi, AA Maia, BR Ferreira, FN Kooyman, IK de Santos
Parasites & vectors 2017
Species-specific differences in regulation of macrophage inflammation by the C3a–C3a receptor axis
TD Ray, S Mekasha, Y Liang, B Lu, S Ram, RR Ingalls
Innate immunity 2017
Renal C3 Complement Component: Feed Forward to Diabetic Kidney Disease
KJ Kelly, Y Liu, J Zhang, JH Dominguez
American Journal of Nephrology 2015
Variation in the Ovine Abomasal Lymph Node Transcriptome between Breeds Known to Differ in Resistance to the Gastrointestinal Nematode
AM Ahmed, B Good, JP Hanrahan, P McGettigan, J Browne, OM Keane, B Bahar, J Mehta, B Markey, A Lohan, T Sweeney, S Sambhara
PloS one 2015
Complement activation in the context of stem cells and tissue repair
IU Schraufstatter
World journal of stem cells 2015
Complement anaphylatoxins as immune regulators in cancer
ET Sayegh, O Bloch, AT Parsa
Cancer Medicine 2014
The Receptor for the Complement C3a Anaphylatoxin (C3aR) Provides Host Protection against Listeria monocytogenes-Induced Apoptosis
SL Mueller-Ortiz, JE Morales, RA Wetsel
Journal of immunology (Baltimore, Md. : 1950) 2014
Dysregulation of complement system and CD4+ T cell activation pathways implicated in allergic response
AC Alves, S Bruhn, A Ramasamy, H Wang, JW Holloway, AL Hartikainen, MR Jarvelin, M Benson, DJ Balding, LJ Coin
PloS one 2013
C3a receptor promotes viral containment in mice inoculated with vaccinia virus at sites of allergic skin inflammation
L Kumar, B Lu, C Gerard, RS Geha
Journal of Allergy and Clinical Immunology 2013
Complement Component 3C3 and C3a Receptor Are Required in Chitin-Dependent Allergic Sensitization to Aspergillus fumigatus but Dispensable in Chitin-Induced Innate Allergic Inflammation
RM Roy, HC Paes, SG Nanjappa, R Sorkness, D Gasper, A Sterkel, M Wuthrich, BS Klein
mBio 2013
Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
TL Spivey, L Uccellini, ML Ascierto, G Zoppoli, VD Giorgi, LG Delogu, AM Engle, JM Thomas, E Wang, FM Marincola, D Bedognetti
Journal of Translational Medicine 2011
A complex role for complement in allergic asthma
Zhang X, Köhl J
Expert Review of Clinical Immunology 2010
Animal models of atopic dermatitis
H Jin, R He, M Oyoshi, RS Geha
Journal of Investigative Dermatology 2009
C3a receptor deficiency accelerates the onset of renal injury in the MRL/lpr mouse
SE Wenderfer, H Wang, B Ke, RA Wetsel, MC Braun
Molecular Immunology 2009
Antigen-driven bystander effect accelerates epicutaneous sensitization with a new protein allergen
LF Wang, JS Chen, CJ Hsu, CY Liu, JS Yu, SC Miaw
Journal of Biomedical Science 2009
Complement activation by CpG in a human whole blood loop system: mechanisms and immunomodulatory effects
SM Mangsbo, J Sanchez, K Anger, JD Lambris, KN Ekdahl, AS Loskog, B Nilsson, TH Tötterman
Journal of immunology (Baltimore, Md. : 1950) 2009
A Protective Role for C5a in the Development of Allergic Asthma Associated with Altered Levels of B7-H1 and B7-DC on Plasmacytoid Dendritic Cells
X Zhang, IP Lewkowich, G Köhl, JR Clark, M Wills-Karp, J Köhl
Journal of immunology (Baltimore, Md. : 1950) 2009
Association study of the C3 gene with adult and childhood asthma
H Inoue, Y Mashimo, M Funamizu, N Shimojo, K Hasegawa, T Hirota, S Doi, M Kameda, A Miyatake, Y Kohno, Y Okamoto, M Tamari, A Hata, Y Suzuki
Journal of Human Genetics 2008
Anaphylatoxins: Their role in bacterial infection and inflammation
PJ Haas, J van Strijp
Immunologic Research 2007
Transcriptional control of complement receptor gene expression
BK Martin
Immunologic Research 2007
Lessons from murine models of atopic dermatitis
T Zheng, Z Zhu
Current Allergy and Asthma Reports 2005
Anaphylatoxin C3a receptors in asthma
H Ali, RA Panettieri
Respiratory Research 2005
New insights into the role of the complement pathway in allergy and asthma
M Wills-Karp, J Koehl
Current Allergy and Asthma Reports 2005
Decay-accelerating factor modulates induction of T cell immunity
PS Heeger, PN Lalli, F Lin, A Valujskikh, J Liu, N Muqim, Y Xu, ME Medof
Journal of Experimental Medicine 2005

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 1 patents
24 readers on Mendeley
See more details